Global Biosimilar Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Report ID: GIR2106060431 | Category: Pharma & Healthcare | Pages: 94 | Format: PDF | Published Date: October 18,2021

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biosimilar Drug size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Biosimilar Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Injection
    Tablets
    Other Types

Market segment by Application can be divided into
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

The key market players for global Biosimilar Drug market are listed below:
    CP Guojian Pharma
    Biotech Pharma
    Celgen Pharma
    Henlius
    Amgen
    Eli Lilly
    Sandoz
    Changchun High Tech
    Innovent

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Biosimilar Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug from 2019 to 2021.
Chapter 3, the Biosimilar Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Biosimilar Drug Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Biosimilar Drug Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Injection
        1.2.3 Tablets
        1.2.4 Other Types
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Biosimilar Drug Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Ankylosing Spondylitis
        1.3.3 Tumor
        1.3.4 Rheumatoid Arthrtis
        1.3.5 Cardiovascular
        1.3.6 Other Application
    1.4 Global Biosimilar Drug Market Size & Forecast
        1.4.1 Global Biosimilar Drug Sales in Value (2016-2026))
        1.4.2 Global Biosimilar Drug Sales in Volume (2016-2026)
        1.4.3 Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
    1.5 Global Biosimilar Drug Production Capacity Analysis
        1.5.1 Global Biosimilar Drug Total Production Capacity (2016-2026)
        1.5.2 Global Biosimilar Drug Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biosimilar Drug Market Drivers
        1.6.2 Biosimilar Drug Market Restraints
        1.6.3 Biosimilar Drug Trends Analysis
2 Manufacturers Profiles
    2.1 CP Guojian Pharma
        2.1.1 CP Guojian Pharma Details
        2.1.2 CP Guojian Pharma Major Business
        2.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
        2.1.4 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Biotech Pharma
        2.2.1 Biotech Pharma Details
        2.2.2 Biotech Pharma Major Business
        2.2.3 Biotech Pharma Biosimilar Drug Product and Services
        2.2.4 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Celgen Pharma
        2.3.1 Celgen Pharma Details
        2.3.2 Celgen Pharma Major Business
        2.3.3 Celgen Pharma Biosimilar Drug Product and Services
        2.3.4 Celgen Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Henlius
        2.4.1 Henlius Details
        2.4.2 Henlius Major Business
        2.4.3 Henlius Biosimilar Drug Product and Services
        2.4.4 Henlius Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Amgen
        2.5.1 Amgen Details
        2.5.2 Amgen Major Business
        2.5.3 Amgen Biosimilar Drug Product and Services
        2.5.4 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Eli Lilly
        2.6.1 Eli Lilly Details
        2.6.2 Eli Lilly Major Business
        2.6.3 Eli Lilly Biosimilar Drug Product and Services
        2.6.4 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Sandoz
        2.7.1 Sandoz Details
        2.7.2 Sandoz Major Business
        2.7.3 Sandoz Biosimilar Drug Product and Services
        2.7.4 Sandoz Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Changchun High Tech
        2.8.1 Changchun High Tech Details
        2.8.2 Changchun High Tech Major Business
        2.8.3 Changchun High Tech Biosimilar Drug Product and Services
        2.8.4 Changchun High Tech Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Innovent
        2.9.1 Innovent Details
        2.9.2 Innovent Major Business
        2.9.3 Innovent Biosimilar Drug Product and Services
        2.9.4 Innovent Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Biosimilar Drug Sales by Manufacturer
    3.1 Global Biosimilar Drug Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Biosimilar Drug Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Biosimilar Drug
    3.4 Market Concentration Rate
        3.4.1 Top 3 Biosimilar Drug Manufacturer Market Share
        3.4.2 Top 6 Biosimilar Drug Manufacturer Market Share
    3.5 Global Biosimilar Drug Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Biosimilar Drug Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Biosimilar Drug Market Size by Region
        4.1.1 Global Biosimilar Drug Sales in Volume by Region (2016-2026)
        4.1.2 Global Biosimilar Drug Revenue by Region (2016-2026)
    4.2 North America Biosimilar Drug Revenue (2016-2026)
    4.3 Europe Biosimilar Drug Revenue (2016-2026)
    4.4 Asia-Pacific Biosimilar Drug Revenue (2016-2026)
    4.5 South America Biosimilar Drug Revenue (2016-2026)
    4.6 Middle East and Africa Biosimilar Drug Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Biosimilar Drug Sales in Volume by Type (2016-2026)
    5.2 Global Biosimilar Drug Revenue by Type (2016-2026)
    5.3 Global Biosimilar Drug Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Biosimilar Drug Sales in Volume by Application (2016-2026)
    6.2 Global Biosimilar Drug Revenue by Application (2016-2026)
    6.3 Global Biosimilar Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Biosimilar Drug Sales by Type (2016-2026)
    7.2 North America Biosimilar Drug Sales by Application (2016-2026)
    7.3 North America Biosimilar Drug Market Size by Country
        7.3.1 North America Biosimilar Drug Sales in Volume by Country (2016-2026)
        7.3.2 North America Biosimilar Drug Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Biosimilar Drug Sales by Type (2016-2026)
    8.2 Europe Biosimilar Drug Sales by Application (2016-2026)
    8.3 Europe Biosimilar Drug Market Size by Country
        8.3.1 Europe Biosimilar Drug Sales in Volume by Country (2016-2026)
        8.3.2 Europe Biosimilar Drug Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Biosimilar Drug Sales by Type (2016-2026)
    9.2 Asia-Pacific Biosimilar Drug Sales by Application (2016-2026)
    9.3 Asia-Pacific Biosimilar Drug Market Size by Region
        9.3.1 Asia-Pacific Biosimilar Drug Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Biosimilar Drug Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Biosimilar Drug Sales by Type (2016-2026)
    10.2 South America Biosimilar Drug Sales by Application (2016-2026)
    10.3 South America Biosimilar Drug Market Size by Country
        10.3.1 South America Biosimilar Drug Sales in Volume by Country (2016-2026)
        10.3.2 South America Biosimilar Drug Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Biosimilar Drug Sales by Type (2016-2026)
    11.2 Middle East & Africa Biosimilar Drug Sales by Application (2016-2026)
    11.3 Middle East & Africa Biosimilar Drug Market Size by Country
        11.3.1 Middle East & Africa Biosimilar Drug Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Biosimilar Drug Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Biosimilar Drug Typical Distributors
    12.3 Biosimilar Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Biosimilar Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?